Cargando…
Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis
INTRODUCTION: The coronavirus disease 2019 (COVID-19) pandemic has increased concern regarding SARS-CoV-2 infection in inflammatory bowel disease (IBD) patients, especially those on immunosuppressive therapies or with active disease. There are limited reports describing the clinical features of COVI...
Autores principales: | Garcia, Karoline Soares, Moutinho, Bruna Damásio, de Azevedo, Matheus Freitas Cardoso, Queiroz, Natalia Sousa Freitas, Milani, Luciane Reis, Sanches, Lucas Navarro, Barros, Luisa Leite, Oba, Jane, Carlos, Alexandre de Sousa, Damião, Aderson Omar Mourão Cintra, Sipahi, Aytan Miranda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493790/ https://www.ncbi.nlm.nih.gov/pubmed/32984404 http://dx.doi.org/10.1159/000508161 |
Ejemplares similares
-
Management of inflammatory bowel disease patients in the COVID-19 pandemic
era: a Brazilian tertiary referral center guidance
por: Queiroz, Natália Sousa Freitas, et al.
Publicado: (2020) -
Active tuberculosis in inflammatory bowel disease patients: a
case–control study
por: Freitas Cardoso de Azevedo, Matheus, et al.
Publicado: (2023) -
Predictive factors of response to infliximab therapy in Brazilian inflammatory bowel disease patients
por: Martins, Camilla de Almeida, et al.
Publicado: (2023) -
Efficacy of Early Optimization of Infliximab Guided by Therapeutic Drug Monitoring during Induction—A Prospective Trial
por: Garcia, Karoline Soares, et al.
Publicado: (2023) -
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
por: Damião, Adérson Omar Mourão Cintra, et al.
Publicado: (2019)